CPTX
LIVE

Serial Number

98714397

Owner

CPTx GmbH

Attorney

Catherine Parrish Lake

Filing Date

Aug 23, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CPTX Trademark

Serial Number: 98714397

CPTX is a trademark filed by CPTx GmbH on August 23, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

CPTx GmbH

Semmelweisstr. 1
Planegg D-82152 , DE

Entity Type: 99

Trademark Details

Filing Date

August 23, 2024

Registration Date

Not Registered

Published for Opposition

January 6, 2026

Goods & Services

Scientific and technological services, namely scientific research and analysis in the field of DNA; biochemical and biotechnological services, namely research and development of custom-specific DNA; research services in the field of DNA, namely, analysis for scientific research purposes and repair technology, mutation and sequencing; biochemical and biotechnological services, namely protein design and development; testing of new products for third parties; scientific DNA screening for scientific research purposes for third parties; protein screening for scientific research purposes for third parties; industrial DNA screening to ensure biopharmaceutical purity and to detect and identify pathogens for third parties for the purposes of scientific and biotechnological research and development; industrial protein screening to ensure biopharmaceutical purity and to detect and identify pathogens for third parties for the purposes of scientific and biotechnological research and development

Pharmaceutical preparations, namely, DNA, synthetic DNA and single-strand DNA for use in the fields of gene therapy, gene editing, cell therapy, cancer therapy, virus production, DNA-vaccination, gene transfer, immunotherapy, and antivirals; Drug delivery agents in the form of synthetic DNA nanostructures that facilitate the delivery of pharmaceutical preparations and therapeutic agents; Medicines comprised of DNA for gene therapy, gene editing, cell therapy, cancer therapy, virus production, DNA-vaccination, gene transfer, immunotherapy, and antivirals; Medicine delivery agents in the form of synthetic DNA nanostructures that facilitate the delivery of pharmaceutical preparations and therapeutic agents; Diagnostic preparations comprising nucleotide sequences for medical and veterinary purposes.

Medical and pharmaceutical services in the field of DNA, namely, medical analysis of DNA for the diagnosis and treatment of persons, DNA screening for medical purposes, genetic testing for medical purposes

Filing History

EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 4, 2026 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 6, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 6, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 31, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 8, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 4, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 4, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 9, 2025 GNFN
FINAL REFUSAL E-MAILED
Oct 9, 2025 GNFR
FINAL REFUSAL WRITTEN
Oct 9, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 11, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 11, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 7, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 7, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 7, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 23, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 23, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 28, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 28, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 28, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 27, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2025 NWOS
NEW APPLICATION ENTERED
Aug 23, 2024 NWAP